Tragara and Lee's Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize TG02 in Greater China Market and South East Asia
November 16, 2015Tragara also announced that it closed a $13 million Series C private financing. Lee's Pharma participated in this financing along with existing investors including Domain Associates, Morgenthaler Ventures, ProQuest Investments and RusnanoMedInvest.
More »
Alimera Sciences Announces New 36-Month Analysis That Shows ILUVIEN® Slows Diabetic Retinopathy Progression
November 16, 2015The significant slowing of the progression of DR when treated with with ILUVIEN, which delivers continuous, low-dose corticosteroid with a single injection, represents a significant benefit which could extend to actual clinical practice and to patients.
More »
aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine for GMP Process Development and for Potential Treatment of Severe Lung Diseases
November 11, 2015The selected iMod.Fc molecule represents an expansion of this new class of therapeutics. aTyr has discovered over 300 Physiocrines that have potential application across many conditions, including diseases of the muscle, lung, gut, skin, brain, and liver.
More »